SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Peregrine Pharmaceuticals (PPHM)

http://www.sec.gov/foia/docs/failsdata.htm http://www.sec.gov/foia/docs/failsdata.htm

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ImaPseudonym Member Profile
 
Followed By 12
Posts 870
Boards Moderated 0
Alias Born 02/09/13
160x600 placeholder
New Study Demonstrates Anti-Tumor Advantages for Combination Treatment Featuring Peregrine Pharmaceuticals’ PS-Targeting An... "GlobeNewswire Inc." - 11/14/2016 8:05:00 AM
Preclinical Research Demonstrates Peregrine Pharmaceuticals’ PS-Targeting Antibodies Enhance the Anti-Tumor Activity of PD-... "GlobeNewswire Inc." - 10/24/2016 8:05:00 AM
Form 8-K - Current report "Edgar (US Regulatory)" - 10/13/2016 4:45:00 PM
Form 8-K - Current report "Edgar (US Regulatory)" - 10/12/2016 2:25:00 PM
Peregrine Pharmaceuticals Reports Top-Line and Initial Biomarker Data from Phase III SUNRISE Trial of Bavituximab in Oral Pre... "GlobeNewswire Inc." - 10/10/2016 8:05:00 AM
Could these companies be setting up for a rebound? "InvestorsHub NewsWire" - 10/6/2016 8:00:00 AM
Peregrine Pharmaceuticals Presents Preclinical Data Demonstrating PS-Targeting Antibodies Significantly Enhance the Anti-Tumo... "GlobeNewswire Inc." - 9/27/2016 8:05:00 AM
Peregrine Pharmaceuticals Provides Update on Oral Presentation of Top-Line Data from Phase III SUNRISE Trial of Bavituximab a... "GlobeNewswire Inc." - 9/21/2016 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2017 and Recent Developments "GlobeNewswire Inc." - 9/8/2016 4:05:00 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 9/6/2016 4:05:00 PM
National Comprehensive Cancer Network (NCCN) Awards Three Grants for Combination Studies of Peregrine Pharmaceuticals’ Bavi... "GlobeNewswire Inc." - 9/6/2016 8:45:00 AM
Peregrine to Report Financial Results for First Quarter of Fiscal Year 2017 After Market Close on September 8, 2016 "GlobeNewswire Inc." - 9/1/2016 4:05:00 PM
Avid Bioservices to Participate in Cambridge Healthtech Institute’s (CHI) 8th Annual The Bioprocessing Summit "GlobeNewswire Inc." - 8/9/2016 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2016 and Recent Developments "GlobeNewswire Inc." - 7/14/2016 4:05:00 PM
Peregrine Licenses Novel Exosome-Based Cancer Detection and Monitoring Technology from UT Southwestern Medical Center "GlobeNewswire Inc." - 7/14/2016 8:05:00 AM
Peregrine to Report Financial Results for the Quarter and Fiscal Year Ended April 30, 2016 After Market Close on July 14, 201... "GlobeNewswire Inc." - 7/7/2016 4:05:00 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 6/2/2016 4:00:00 PM
Peregrine Pharmaceuticals Provides Corporate Update Highlighting Latest Developments for Contract Manufacturing and Drug Deve... "GlobeNewswire Inc." - 6/2/2016 8:05:00 AM
Preclinical Data Presented at American Association for Cancer Research (AACR) Annual Meeting Demonstrate Enhanced Therapeutic... "GlobeNewswire Inc." - 4/20/2016 8:05:00 AM
Form 8-K - Current report "Edgar (US Regulatory)" - 4/12/2016 4:31:41 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 3/9/2016 7:46:45 PM
Peregrine Pharmaceuticals Announces Formal Commissioning of New, State-of-the-Art Commercial Manufacturing Facility "GlobeNewswire Inc." - 3/9/2016 7:46:43 PM
Peregrine to Report Financial Results for Third Quarter of Fiscal Year 2016 Prior to Market Open on March 9, 2016 "GlobeNewswire Inc." - 3/9/2016 7:46:38 PM
Peregrine Pharmaceuticals Provides Update on Phase III SUNRISE Trial of Bavituximab "GlobeNewswire Inc." - 3/9/2016 7:46:14 PM
Peregrine Pharmaceuticals Reports Financial Results for Third Quarter of Fiscal Year 2016 and Recent Developments "GlobeNewswire Inc." - 3/9/2016 8:00:00 AM
ImaPseudonym   Friday, 03/01/13 11:42:35 AM
Re: jakedogman1 post# 114529
Post # of 280216 
http://www.sec.gov/foia/docs/failsdata.htm

There is also a link on the deep capture blog that gives it as a nice graph.

**Caution: Some believe that I am a basher or a short and any positive posts are to gain trust, while my real goal is to cause doubt and make you sell. I assert I am a long, but decide for yourself and please don't buy or sell based on anything I say.**
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist